Involvement of the Fcγ receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection

Journal of General Virology

Volumn 91, Issue 1, 2010, Pages 103-111

  Moi, Meng Ling ^a,b   Lim, Chang Kweng ^a   Takasaki, Tomohiko ^a   Kurane, Ichiro ^a,b  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR IIA;

ANIMAL CELL; ANTIBODY DEPENDENT ENHANCEMENT; ARTICLE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; GENE DISRUPTION; GENE MUTATION; IN VITRO STUDY; MONOCYTE; NONHUMAN; NUCLEOTIDE SEQUENCE; PALMITOYLATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY-DEPENDENT ENHANCEMENT; CERCOPITHECUS AETHIOPS; COS CELLS; DENGUE VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; RECEPTORS, IGG;

DENGUE VIRUS;

EID: 73149121891     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.014829-0     Document Type: Article

References (34)

1. Abdel Shakor, A. B., Kwiatkowska, K. & Sobota, A. (2004). Cell surface ceramide generation precedes and controls FcγRII clustering and phosphorylation in rafts. J Biol Chem 279, 36778-36787.
2. An, T. (1982). Rapid endocytosis of soluble immune complexes by Fc receptors of normal human neutrophils. Immunology 45, 413-422.
3. Anderson, K. B., Chunsuttiwat, S., Nisalak, A., Mammen, M. P., Libraty, D. H., Rothman, A. L., Green, S., Vaughn, D. W., Ennis, F. A. & Endy, T. P. (2007). Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 369, 1452-1459.
4. Barabé, F., Rollet-Labelle, E., Gilbert, C., Fernandes, M. J., Naccache, S. N. & Naccache, P. H. (2002). Early events in the activation of FcγRIIA in human neutrophils: stimulated insolubilization, translocation to detergent-resistant domains, and degradation of FcγRIIA. J Immunol 168, 4042-4049.
5. Barnes, N. C., Powell, M. S., Trist, H. M., Gavin, A. L., Wines, B. D. & Hogarth, P. M. (2006). Raft localisation of FcγRIIA and efficient signaling are dependent on palmitoylation of cysteine 208. Immunol Lett 104, 118-123.
6. Booth, J. W., Kim, M., Jankowski, A., Schreiber, A. D. & Grinstein, S. (2002). Contrasting requirements for ubiquitylation during Fc receptor-mediated endocytosis and phagocytosis. EMBO J 21, 251-258.
7. Brooks, D. G., Qiu, W. Q., Luster, A. D. & Ravetch, J. V. (1989). Structure and expression of human IgG FcRII (CD32). J Exp Med 170, 1369-1385.
8. Davis, W., Harrison, P. T., Hutchinson, M. J. & Allen, J. M. (1995). Two distinct regions of FcγRI initiate separate signalling pathways involved in endocytosis and phagocytosis. EMBO J 14, 432-441.
9. García-García, E. & Rosales, C. (2002). Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol 72, 1092-1108.
10. Gessner, J. E., Heiken, H., Tamm, A. & Schmidt, R. E. (1998). The IgG Fc receptor family. Ann Hematol 76, 231-248.
11. Graham, R. R., Juffrie, M., Tan, R., Hayes, C. G., Laksono, I., Ma'roef, C., Erlin, Sutaryo, Porter, K. R. & Halstead, S. B. (1999). A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia. I. Studies in 1995-1996. Am J Trop Med Hyg 61, 412-419.
12. Huang, M. M., Indik, Z., Brass, L. F., Hoxie, J. A., Schreiber, A. D. & Brugge, J. S. (1992). Activation of FcγRII induces tyrosine phosphorylation of multiple proteins including FccRII. J Biol Chem 267, 5467-5473.
13. Indik, Z., Kelly, C., Chien, P., Levinson, A. I. & Schreiber, A. D. (1991). Human FcγRII, in the absence of other Fcγ receptors, mediates a phagocytic signal. J Clin Invest 88, 1766-1771.
14. Indik, Z. K., Park, J. G., Hunter, S. & Schreiber, A. D. (1995a). Structure/function relationships of Fcγ receptors in phagocytosis. Semin Immunol 7, 45-54.
15. Indik, Z. K., Park, J. G., Hunter, S. & Schreiber, A. D. (1995b). The molecular dissection of Fcγ receptor mediated phagocytosis. Blood 86, 4389-4399.
16. Ito, M., Yamada, K., Takasaki, T., Pandey, B., Nerome, R., Tajima, S., Morita, K. & Kurane, I. (2007). Phylogenetic analysis of dengue viruses isolated from imported dengue patients: possible aid for determining the countries where infections occurred. J Travel Med 14, 233-244.
17. Kim, M.-K., Huang, Z.-Y., Hwang, P.-H., Jones, B. A., Sato, N., Hunter, S., Kim-Han, T.-H., Worth, R. G., Indik, Z. K. & Schreiber, A. D. (2003). Fcγ receptor transmembrane domains: role in cell surface expression, γ chain interaction, and phagocytosis. Blood 101, 4479-4484.
18. Kindzelskii, A. L., Xue, W., Todd, R. F., III, Boxer, L. A. & Petty, H. R. (1994). Abberant capping of membrane proteins on neutrophils from patients with leukocyte adhesion deficiency. Blood 83, 1650-1655.
19. Kontny, U., Kurane, I. & Ennis, F. A. (1988). Gamma interferon augments Fcγ receptor-mediated dengue virus infection of human monocytic cells. J Virol 62, 3928-3933.
20. Kurane, I. & Ennis, F. (1992). Immunity and immunopathology in dengue virus infections. Semin Immunol 4, 121-127.
21. Kwiatkowska, K., Frey, J. & Sobota, A. (2003). Phosphorylation of FcγRIIA is required for the receptor-induced actin rearrangement and capping: the role of membrane rafts. J Cell Sci 116, 537-550.
22. Littaua, R., Kurane, I. & Ennis, F. A. (1990). Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 144, 3183-3186.
23. Mady, B. J., Erbe, D. V., Kurane, I., Fanger, M. W. & Ennis, F. A. (1991). Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fcγ receptors. J Immunol 147, 3139-3144.
24. Mero, P., Zhang, C. Y., Huang, Z., Kim, M., Schreiber, A. D., Grinstein, S. &Booth, J. W. (2006). Phosphorylation-independent ubiquitylation and endocytosis of FcγRIIA. J Biol Chem 281, 33242-33249.
25. Mitchell, M. A., Huang, M. M., Chien, P., Indik, Z. K., Pan, X. Q. & Schreiber, A. D. (1994). Substitutions and deletions in the cytoplasmic domain of the phagocytic receptor FcγRIIA: effect on receptor tyrosine phosphorylation and phagocytosis. Blood 84, 1753-1759.
26. Noisakran, S. & Perng, G. C. (2008). Alternate hypothesis on the pathogenesis of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in dengue virus infection. Exp Biol Med (Maywood) 233, 401-408.
27. Okanurak, K., Sornmani, S. & Indaratna, K. (1997). The cost of dengue hemorrhagic fever in Thailand. Southeast Asian J Trop Med Public Health 28, 711-717.
28. Ravetch, J. V. & Kinet, J. P. (1991). Fc receptors. Annu Rev Immunol 9, 457-492.
29. Rodrigo, W. W., Jin, X., Blackley, S. D., Rose, R. C. & Schlesinger, J. J. (2006). Differential enhancement of dengue virus immune complex infectivity mediated by signaling-competent and signaling-incompetent human FcγRIA (CD64) or FcγRIIA (CD32). J Virol 80, 10128-10138.
30. Ruangjirachuporn, W., Boonpucknavig, S. & Nimmanitya, S. (1979). Circulating immune complexes in serum from patients with dengue haemorrhagic fever. Clin Exp Immunol 36, 46-53.
31. Sangkawibha, N., Rojanasuphot, S., Ahandrik, S., Viriyapongse, S., Jatanasen, S., Salitul, V., Phanthumachinda, B. & Halstead, S. B. (1984). Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 120, 653-669.
32. Schlesinger, J. J. & Chapman, S. E. (1999). Influence of the human high-affinity IgG receptor FcγRI (CD64) on residual infectivity of neutralized dengue virus. Virology 260, 84-88.
33. Sobota, A., Strzelecka-Kiliszek, A., G3adkowska, E., Yoshida, K., Mrozin' ska, K. & Kwiatkowska, K. (2005). Binding of IgG-opsonized particles to FcγR is an active stage of phagocytosis that involves receptor clustering and phosphorylation. J Immunol 175, 4450-4457.
34. Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L. & other authors (2000). Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 181, 2-9.